VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction

Mol Ther. 2024 Nov 6;32(11):4160-4162. doi: 10.1016/j.ymthe.2024.10.002. Epub 2024 Oct 10.
No abstract available

Publication types

  • Published Erratum